- New alliance will crack down on adulterated products touting dietary supplement claims
- Mylan's generic Precose gets green light from FDA
- Mylan's Hyzaar, Cozaar generics receive OK from FDA
- Mylan subsidiary gets approval for HIV generic under PEPFAR
- Mylan gets nod for additional strengths of generic Mirapex
PITTSBURGH — The Food and Drug Administration has approved a generic drug for epilepsy made by Mylan.
Mylan said Monday that the FDA had approved its divalproex sodium capsules in the 125-mg strength. The drug is a generic version of Abbott’s Depakote Sprinkle capsules and is used to treat certain types of epileptic seizures.
Divalproex sodium capsules had sales of about $89 million during the 12-month period ended in March, according to IMS Health.